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Objective: To examine the relationship of knee osteoarthritis (OA) with cardiovascular and metabolic risk
factors by obesity status and gender.
Methods: Data from 1,066 National Health and Nutrition Examination Survey III participants (60 years
of age) was used to examine relationships of osteophytes-deﬁned radiographic knee OA and cardio-
vascular and metabolic measures. Analyses were considered among obese [body mass index (BMI)
30 kg/m2] and non-obese (BMI< 30 kg/m2) men and women.
Results: The prevalence of osteophytes-deﬁned radiographic knee OA was 34%. Leptin levels and
homeostatic model assessment-insulin resistance (HOMA-IR), a proxy measure of insulin resistance,
were signiﬁcantly associated with knee OA; those with knee OA had 35% higher HOMA-IR values and 52%
higher leptin levels compared to those without knee OA. The magnitude of the association between
HOMA-IR and knee OA was strongest among men, regardless of obesity status; odds ratios (ORs) for
HOMA-IR were 34% greater among non-obese men (OR¼ 1.18) vs obese women (OR¼ 0.88). Among
obese women, a 5-mg/L higher leptin was associated with nearly 30% higher odds of having knee OA
(OR¼ 1.28). Among men, ORs for the association of leptin and knee OA were in the opposite direction.
Conclusions: Cardiometabolic dysfunction is related to osteophytes-deﬁned radiographic knee OA prev-
alence and persists within subgroups deﬁned by obesity status and gender. A sex dimorphism in the
direction and magnitude of cardiometabolic risk factors with respect to knee OA was described including
HOMA-IR being associated with OA prevalence among men while leptin levels were most important
among women.
 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is a highly prevalent disorder, affecting
approximately 27million Americans1. Estimates from a population-
based study predict that one of every two elderly adults will have
knee OA2. Arthritis generates substantial economic burden as
a result of health care expenditures3, decrements in physical
functioning4,5 and loss in productivity associated with physical
disability6.
Obesity is a widely-acknowledged risk factor for knee OA7e9.
There is a growing appreciation of the need to understand howCarrie A. Karvonen-Gutierrez,
emiology, 1415 Washington
734-763-0571; Fax: 734-764-
en-Gutierrez).
s Research Society International. Pobesity contributes to OA considering the increasing prevalence of
obesity and overweight in the US and world-wide10,11, the under-
lying inﬂammatory component in both obesity and OA12, and the
knowledge that few interventions have been successful without
addressing either weight or the inﬂammatory response13.
Several mechanisms have been proposed by which obesity can
inﬂuence OA onset and progression [reviewed by Sowers & Kar-
vonen-Gutierrez14]. Some investigations have concluded that the
primary role for obesity in OA etiology is as a sheer mechanical
force leading to increased joint loading and subsequent articular
cartilage damage15,16. However, this does not explain the associa-
tions observed between obesity and OA in non-weight bearing
joints7,17e19 thereby motivating additional and alternative expla-
nations of the OA-obesity relationship. The recognition that
adipose tissue can contribute to changing metabolic environments
has stimulated the consideration of hypotheses about the rela-
tionship of obesity and OA that extend beyond those ofublished by Elsevier Ltd. All rights reserved.
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bolic environment of chondrocytes, including glucose transport,
cholesterol efﬂux and lipid metabolism [reviewed by Katz20] have
led investigators to consider novel obesity-related biomarkers that
may reﬂect underlying pathology between OA and the cardiovas-
cular and metabolic diseases.
Findings from studies that have examined cardiovascular or
metabolic risk factors and OA are mixed. Some21e23, but not all
studies24,25 have found positive associations of OA with cardio-
vascular risk factors. Importantly, studies of OA and obesity that
have included cardiometabolic measures have rarely incorporated
measures of fat tissue metabolism such as leptin, an adipocytokine
that is an important modulator of the inﬂammatory response26.
Synthesis and secretion of leptin have been demonstrated in
osteoblasts and chondrocytes27,28 and its receptors have been
identiﬁed in articular cartilage29. Importantly, leptin levels are
associated with markers of bone formation and leptin receptor is
associated with greater cartilage loss30.
In an effort to further elucidate the role of cardiometabolic
dysfunction with respect to OA, we report the relationship of
cardiovascular and metabolic risk factors with radiographically-
deﬁned knee OA among a sample of men and women aged 60
and over, representative of the United States population. We
hypothesized that individuals with greater insulin resistance,
poorer lipid proﬁles, and greater leptin levels would have an
increased odds of knee OA. We further hypothesized that the
magnitude of these relationships would differ by gender.
Methods
Data source and sample
Data are from the National Health and Nutrition Examination
Survey (NHANES) III, a survey of the civilian non-institutionalized
US population conducted by the National Center for Health Statis-
tics (NCHS) from 1988 to 1994. NHANES III utilized a stratiﬁed
multistage probability sampling design, including a two-phase
survey period. Adults aged 60þ years, African-Americans and
Mexican Americans were oversampled to provide stable estimates
of health characteristics for these subgroups.
These analyses address a subset of the total NHANES III sample
as only adults aged 60þ years were recruited for the radiograph
acquisition component and only Phase 2 (1991e1994) knee radio-
graphs have been scored for osteophytes-deﬁned OA severity.
There were no medical, safety or other exclusions for the radio-
graph component; the overall completion rate for obtaining
radiographs from eligible participants was 93%. Furthermore, only
data from thosewithmorning visits whowere fasted and had blood
assayed for leptin were considered for these analyses. Study
subjects were randomly assigned to the morning group and
samples were randomly selected for leptin assay. Thus, this report
is based upon data from 1,066 adults aged 60 years or greater with
knee OA data and fasted blood samples available for assay. Partic-
ipants with data available to be included in this sample are more
likely to be Caucasian but less likely to have a high school education
as compared to the total NHANES sample. Further, they have
a higher body mass index (BMI) and are older, as is expected given
that age was part of the inclusion criterion for the radiograph
protocol.
OA measures
Knee OA was deﬁned using non-weight bearing anterio-poste-
rior knee radiographs from a Centrix III x-ray unit with Kodak Lanex
double screens and TML ﬁlm (phototimed with 12:1 stationarygrid). Radiographs were scored for osteophytes-deﬁned OA severity
using the KellgreneLawrence (KL) Atlas of Knee Radiographs of
Arthritis31, where zero¼ normal, one¼ possible osteophyte,
two¼ deﬁnite osteophyte, three¼moderate multiple osteophytes,
and four¼ large osteophytes, severe sclerosis. Those with a KL
score 2 or those with knee joint replacements were considered to
have osteophytes-deﬁned radiographic OA.
Knee radiographs were read by one of two radiologists with
additional scoring by a second reader if there was evidence of
disease. Scores from the two readers were compared and discor-
dant scores were subjected to consensus readings. The quality
control program has been described32. For the KL scoring, Kappa
statistics for inter-rater agreement were >0.71; for intra-rater
agreement the Kappa scores were >0.84 and >0.82 for the
primary and secondary reader, respectively.
Cardiometabolic measures
The primary independent variables were cardiometabolic risk
factors, including a proxy indicator of insulin resistance homeo-
static model assessment-insulin resistance (HOMA-IR), high-
density lipoprotein cholesterol (HDL-c), low-density lipoprotein
cholesterol (LDL-c), triglycerides, waist:hip ratio, blood pressure,
and leptin. Each individual was classiﬁed as either non-obese
(BMI< 30 kg/m2) or obese (BMI 30 kg/m2). Assay information is
available as Online Supplemental Material (eMethods) and in the
NHANES III reference documents33,34. HOMA-IR was calculated
using the following formula: [Insulin uIU/mL (Glucose mg/
dL 0.055)/22.5].
Blood pressure was measured three times by trained personnel
and recorded to the nearest even number, according to a stan-
dardized protocol. The average of the three measurements was
used in data analysis. Height (cm) was measured using a stadi-
ometer. Weight (kg) was measured using a digital scale. BMI was
calculated as [weight(kg)/height(m)2].Waist and hip circumference
(cm) were measured using a nonstretching tape.
Other variables
Age was measured in years. Other demographic variables were
analyzed as categorical variables, as follows: self-reported race/
ethnic group (non-Hispanic White, non-Hispanic Black, Mexican
American, and Other), gender, marital status (married vs not
married), educational attainment (less than high school vs high
school or more). Referent groups were non-Hispanic Whites, those
not married and those with less than a high school education.
All data, including radiographs, specimen collection for assay of
cardiometabolic measures, measurement of body size and self-
reported demographic information were collected at the same
visit. NHANES III was approved by the NCHS Institutional Review
Board. Written informed consent was obtained from all
participants.
Statistical analysis
NHANES III pseudo-stratum (SDPSTRA6), pseudo-cluster
(SDPPSU6) and Phase 2 morning session subsample weight
(WTPFSD2) variables were used in all analyses. WTPFSD2 was
selected as the sample weight because only knee radiographs from
Phase 2 were scored and because leptin was only assayed among
participants from the morning session. Missing data was handled
using case-wise deletion. Because of the small number of “Other”
race/ethnicity, data from these participants were excluded from
multivariate analyses. Potential demographic and cardiometabolic
variables of interest were selected a priori given the availability of
Fig. 1. Prevalence (95% CI) of osteophytes-deﬁned radiographic knee OA by obesity
status and gender among NHANES III sample.
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risk factors for knee OA.
Univariate distributions of the continuous variables of age and
the cardiometabolic measures were examined, overall and by
osteophytes-deﬁned radiographic knee OA status and reported as
means and standard errors (SEs). Distributions were examined for
normalcy. While leptin and HOMA-IR were not normally distrib-
uted, they were modeled on their original scale to ease with
interpretation of results. Frequencies of the categorical variables
were examined, overall and by osteophytes-deﬁned radiographic
knee OA group, to ensure sufﬁcient sample sizes in individual cells
for appropriate analyses. Categorical variables are reported as
percentages and SEs.
The unadjusted relationships of the continuous cardiometabolic
biomarkers and knee OA were characterized using logistic regres-
sion models (SAS PROC SURVEYLOGISTIC). Bivariate (unadjusted)
associations of knee OA and categorical independent predictors
were evaluated using Rao-Scott Chi-Square tests.
All variables were considered for inclusion in the multivariable
analysis; variables were retained in the ﬁnal models if the adjusted
estimates changed by 10% or more as compared to the unadjusted
analysis. Some variables were not retained in the ﬁnal model due to
collinearity concerns with other variables. Because HOMA-IR is
calculated from glucose and insulin, thesemeasures could not all be
included in the ﬁnal multivariable model. HOMA-IR, a proxy of
insulin resistance, was selected for multivariable modeling. Simi-
larly, diastolic blood pressure (DBP) was not included in the ﬁnal
model due to collinearity concerns with systolic blood pressure
(SBP). Given that differences in DBP were relatively small between
knee OA groups and not clinically signiﬁcant, SBP was selected for
inclusion in the ﬁnal model. The two measures of body size, BMI
and waist:hip ratio could not be included in the same model.
Covariate-adjusted models were stratiﬁed by obesity status and
gender because of signiﬁcant interactions between these variables
and the independent cardiometabolic variables of interest.
Regression diagnostics were examined for the ﬁnal multivariable
model and there was no evidence of collinearity among the
included variables.
A sensitivity analysis was conducted to examine the consistency
of the observations from the multivariable models after adjustment
for waist:hip ratio instead of BMI within obesity and gender
stratum. SAS Version 9.2 (SAS Institute, Cary, NC, USA) was used for
all data analyses.
Results
This sample (N¼ 1,066) with knee radiographs included non-
Hispanic Whites (83.2%), non-Hispanic Blacks (7.3%), Mexican
Americans (2.3%) and Other race/ethnicity (7.2%). The design-
adjusted mean age of the sample was 70.5 years (SE¼ 0.14) with
57% being female.
After considering the survey sampling design, 34.1%
(SE¼ 0.60%) of individuals had osteophytes-deﬁned radiographic
knee OA as deﬁned as a KL score 2; obese men and obese women
had the greatest prevalence of osteophytes-deﬁned radiographic
knee OA (Fig. 1). Individuals with osteophytes-deﬁned radiographic
knee OA were, on average, 2 years older (P< 0.0001) and were
more likely to be female, non-Hispanic Black, unmarried, less
educated and a never smoker in comparison to those without knee
OA (Table I).
Female participants were 1.1 years older, were less likely to be
married but more likely to have completed high school as
compared to male participants. Further, more women were never
smokers whereas more men were former smokers (Table II).
Women were more likely to be categorized as normal weight orobese as compared to men but there was no difference in the BMI
between men and women. Women had lower glucose, triglyceride
and DBP levels as compared to men but higher HDL-c, LDL-c, and
SBP. Notably, design-adjusted average leptin levels were more than
two times greater among women as compared tomen (P< 0.0001).
Body size, cardiometabolic characteristics and knee OA
The design-adjusted average BMI among those with
osteophytes-deﬁned radiographic knee OA was 29.4 kg/m2
compared to 26.0 kg/m2 among those without knee OA
(P< 0.0001). While one-fourth of the total sample (25.3%) was
classiﬁed as obese, 40% of those with osteophytes-deﬁned radio-
graphic knee OA were classiﬁed as obese.
With the exception of waist:hip ratio, all of the cardiometabolic
factors were signiﬁcantly associated with osteophytes-deﬁned
radiographic knee OA status. Those with knee OA had 35% higher
HOMA-IR values and 52% higher leptin levels as compared to those
without knee OA. While statistically signiﬁcant, lipids were only
2e7% worse in those with knee OA while blood pressure levels
were 1e3% higher compared to those without knee OA.
Sexdimorphismwith respect to cardiometabolic characteristics andOA
After adjustment for BMI, HOMA-IR and leptin levels had the
strongest relationships with osteophytes-deﬁned radiographic
knee OA in multivariable models that included all of the car-
diometabolic measures (leptin, HOMA-IR, LDL-c, SBP, triglycerides)
and adjustment for age, race/ethnicity, marital status, educational
attainment and smoking status (Table III). The magnitude of the
association between HOMA-IR and knee OA was much greater
among men than women. Among non-obese and obese men,
respectively, each higher unit in HOMA-IR was associated with
18e34% greater odds (OR¼ 1.18, 95% conﬁdence interval (CI) 1.15,
1.22 and OR¼ 1.34, 95% CI 1.27, 1.42) of having osteophytes-deﬁned
radiographic knee OA. Among non-obesewomen, a one-unit higher
HOMA-IRwas associatedwith only 4% greater odds of knee OA (95%
CI 1.01, 1.07) while HOMA-IR was actually associated with
decreased odds of knee OA among obese women (Fig. 2).
Leptin levels were strongly associated with osteophytes-deﬁned
radiographic knee OA. Among obese women, a 5 mg/L higher leptin
was associated with 28% greater odds of having knee OA (OR¼ 1.28,
95% CI 1.26, 1.31). Among non-obese women, the magnitude of the
association between leptin levels and knee OA was less although
statistically signiﬁcant (OR¼ 1.04, 95% CI 1.01, 1.07). The relation-
ship of leptin and knee OA was reversed in men compared to
women. A 5 mg/L higher level of leptin was associated with 27%
decreased odds of having knee OA among obese men, and 39%
decreased odds of having knee OA among non-obese men (Fig. 3).
LDL-c was signiﬁcantly and positively associated with
osteophytes-deﬁned radiographic knee OA among obese and non-
Table I
Demographic and cardiometabolic features of NHANES III participants aged 60þ years, by osteophytes-deﬁned radiographic knee OA status*
No osteophytes-deﬁned radiographic knee OA
N¼ 632
Osteophytes-deﬁned radiographic knee OA
N¼ 434
P-value knee OA vs no knee OA
n (%, SE %) n (%, SE %)
Sex
Male 340 (69.6%, 1.3) 172 (30.4%, 1.3) <0.0001
Female 292 (58.4%, 1.1) 262 (41.6%, 1.1)
Race/ethnicity
Non-Hispanic White 368 (63.5%, 1.0) 242 (36.5%, 1.0) <0.0001
Non-Hispanic Black 99 (52.0%, 2.2) 94 (48.0%, 2.2)
Mexican American 133 (60.9%, 2.7) 84 (39.1%, 2.7)
Other 32 (70.7%, 5.0) 14 (29.3%, 5.0)
Marital status
Married 399 (65.3%, 0.6) 235 (34.7%, 0.6) <0.0001
Not married 232 (59.9%, 1.0) 197 (40.1%, 1.0)
Educational attainment
Less than high school 346 (60.7%, 0.5) 254 (39.3%, 0.5) <0.0001
High school or more 284 (64.9%, 1.9) 179 (35.1%, 1.9)
Smoking status
Current 119 (75.5%, 1.2) 45 (24.5%, 1.2) <0.0001
Former 243 (66.9%, 1.7) 142 (33.1%, 1.7)
Never 270 (56.5%, 1.2) 247 (43.5%, 1.2)
BMI category
BMI< 25 kg/m2 253 (78.1%, 1.0) 88 (21.9%, 1.0) <0.0001
BMI 25e29.9 kg/m2 268 (63.7%, 1.4) 175 (36.3%, 1.4)
BMI 30 kg/m2 110 (41.4%, 1.2) 170 (58.6%, 1.2)
Mean (SE) Mean (SE)
Age 69.8 (0.14) 71.7 (0.07) <0.0001
BMI, kg/m2 26.0 (0.03) 29.4 (0.13) <0.0001
Cardiometabolic factors
Glucose (mg/dL) 108.3 (0.39) 116.2 (0.41) <0.0001
Insulin (uIU/mL) 10.9 (0.08) 13.9 (0.23) <0.0001
HOMA-IR 3.1 (0.03) 4.2 (0.05) <0.0001
HDL-cholesterol (mg/dL) 52.6 (0.39) 51.7 (0.35) 0.02
LDL-cholesterol (mg/dL) 137.2 (0.48) 143.4 (0.80) <0.0001
Triglycerides (mg/dL) 155.1 (1.28) 167.1 (1.43) <0.0001
Waist:hip ratio 0.95 (0.001) 0.96 (0.002) 0.38
SBP 136.8 (0.37) 141.6 (0.19) <0.0001
DBP 73.6 (0.12) 74.5 (0.08) <0.0001
Leptin (mg/L) 11.8 (0.07) 18.0 (0.28) <0.0001
*All data are design-adjusted (using weights, cluster and stratum variables) to account for the survey sample design. Bold values indicate ﬁndings that are statistically
signiﬁcant.
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among obese women (P< 0.0001) (Table III). For both obese and
non-obese men, a 5 mg/dL higher LDL-c was associated with 5e6%
greater odds of knee OA. Conversely, for obese women, a 5 mg/dL
increase in LDL-c was associated with 6% decreased odds of having
knee OA. LDL-c was not associated with knee OA among non-obese
women (Table III).
The relationship of SBP and osteophytes-deﬁned radiographic
knee OA was also different among men and women, regardless of
obesity status. A 5 mmHg increase in SBP was associated with
3e12% decreased odds of having knee OA among men but with
9e10% increased odds of having knee OA among women (Table III).
BMI was associated with having osteophytes-deﬁned radio-
graphic knee OA among women. A 1 kg/m2 increase in BMI was
associated with 15e18% increased odds of having knee OA among
women. However, amongmen, the relationship of BMI and knee OA
differed based on obesity status. In non-obese men, a 1 kg/m2
increase in BMI was associated with 30% increased odds of having
knee OA (OR¼ 1.33, 95% CI 1.29,1.36). Among obese men, however,
BMI was not associated with having knee OA.
When multivariable analyses were adjusted for waist:hip ratio
instead of BMI as a sensitivity analysis, estimates for LDL-c and SBP
were virtually unchanged in terms of magnitude or direction (data
not shown). Odds ratios (ORs) for HOMA-IR changed very little
(<5%) and ORs for leptin changed by 3e12% among women andobese men in models adjusted for waist:hip ratio instead of BMI.
Changes were more pronounced among non-obese men (þ16%
change for HOMA-IR and þ26% change for leptin).
Discussion
Using data from a nationally-representative sample of the US
elderly population, the importance of obesity as a risk factor for
osteophytes-deﬁned radiographic knee OA was conﬁrmed. The
prevalence of obesity was twice as great among those having knee
OA as compared to those without knee OA. There were also very
strong associations of having osteophytes-deﬁned radiographic
knee OA with cardiometabolic characteristics, even following
adjustment for body size using BMI. Most importantly, we report
compelling and consistent relationships of HOMA-IR and leptin,
two obesity-related biomarkers, with knee OA. Notably, the over-
whelming difference in the magnitude and direction of these
associations had to be considered within the context of being male
or female. Striking sex differences were observed for HOMA-IR and
leptin in relation to having osteophytes-deﬁned radiographic knee
OA. ORs for HOMA-IR were 14% greater among non-obese men vs
non-obese women. For those who were obese, the odds of having
knee OA increase substantially with increasing HOMA-IR among
men; however, among obese women, the ORs for HOMA-IR were in
the opposite direction. Conversely, leptin levels were most
Table II
Demographic and cardiometabolic features of NHANES III participants aged
60þ years by gender*
Male
N¼ 517
Female
N¼ 554
P-value
male vs
female
n (%, SE %) n (%, SE %)
Race/ethnicity
Non-Hispanic White 275 (83.2%, 1.0) 335 (83.3%, 0.5) 0.50
Non-Hispanic Black 91 (6.9%, 0.3) 102 (7.5%, 0.6)
Mexican American 126 (2.5%, 0.1) 91 (2.1%, 0.2)
Other 20 (7.4%, 1.2) 26 (7.1%, 0.8)
Marital status
Married 400 (81.0%, 0.3) 234 (46.9%, 1.0) <0.0001
Not married 112 (19.0%, 0.3) 317 (53.1%, 1.0)
Educational attainment
Less than high school 307 (43.6%, 1.0) 293 (40.5%, 1.2) 0.004
High school or more 205 (56.4%, 1.0) 258 (59.5%, 1.2)
Smoking status
Current 96 (17.1%, 0.8) 68 (13.1%, 0.6) <0.0001
Former 258 (51.3%, 0.7) 127 (26.4%, 0.5)
Never 158 (31.5%, 0.7) 359 (60.6%, 0.8)
BMI category
BMI< 25 kg/m2 160 (31.6%, 0.8) 181 (38.0%, 0.7) <0.0001
BMI 25e29.9 kg/m2 239 (44.5%, 1.0) 204 (36.0%, 0.8)
BMI 30 kg/m2 113 (24.0%, 0.9) 167 (26.0%, 0.8)
Mean (SE) Mean (SE)
Age 69.9 (0.16) 71.0 (0.16) <0.0001
BMI, kg/m2 27.2 (0.05) 27.3 (0.11) 0.49
Cardiometabolic factors
Glucose (mg/dL) 115.3 (0.90) 108.2 (0.23) <0.0001
Insulin (uIU/mL) 11.4 (0.14) 12.0 (0.16) 0.68
HOMA-IR 3.6 (0.07) 3.4 (0.04) 0.06
HDL-cholesterol (mg/dL) 46.5 (0.65) 56.5 (0.28) <0.0001
LDL-cholesterol (mg/dL) 135.1 (0.88) 142.7 (0.76) <0.0001
Triglycerides (mg/dL) 160.5 (1.59) 158.9 (1.66) 0.39
Waist:hip ratio 1.006 (0.001) 0.92 (0.001) <0.0001
SBP 137.1 (0.46) 139.7 (0.32) <0.0001
DBP 75.7 (0.17) 72.6 (0.04) <0.0001
Leptin (mg/L) 7.6 (0.08) 18.9 (0.29) <0.0001
*All data are design-adjusted (using weights, cluster and stratum variables) to
account for the survey sample design. Bold values indicate ﬁndings that are statis-
tically signiﬁcant.
Fig. 2. OR (95% CI) of osteophytes-deﬁned radiographic knee OA associated with
HOMA-IR by gender and obesity status, NHANES III. Estimates from each of the four
obesity by sex models were adjusted for age, ethnicity, marital status, educational
attainment, smoking status, leptin, BMI, logtriglycerides, LDL-c, and SBP.
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OA amongwomen compared tomen.We found that higher leptin is
associated with increased odds of knee OA among women but the
opposite was observed in men. These relationships with car-
diometabolic risk factors were observed in multivariable models
also adjusting for BMI. Our ﬁndings suggest that the impact of
leptin has an independent effect on knee OA prevalence among
women, over-and-above the effect of body size alone.
Sex dimorphism with respect to body composition is well-
reported in the literature, suggesting that fatness means something
different for men vs women. For a given level of BMI, women
generally have a larger proportion of body mass that is fat as
compared to men and women are more likely to deposit adiposeTable III
Adjusted ORs (95% CIs) for the association between cardiometabolic factors and osteophy
NHANES III*
Models in the following stratum Leptiny HOMA-IR
OR (95% CI) OR (95% CI)
Non-obese men (N¼ 372) 0.61 (0.56, 0.67) 1.18 (1.15, 1.22)
Obese men (N¼ 102) 0.73 (0.70, 0.77) 1.34 (1.27, 1.42)
Non-obese women (N¼ 356) 1.04 (1.01, 1.07) 1.04 (1.01, 1.07)
Obese women (N¼ 148) 1.28 (1.26, 1.31) 0.88 (0.86, 0.89)
* All models are adjusted for age, ethnicity, marital status, educational attainment, log
y Estimates for leptin reﬂect a 5 mg/L increase in leptin.
z Estimates for LDL-c represent a 5 mg/dL increase in LDL-c.
x Estimates for SBP represent a 5 mmHg increase in SBP. Bold values indicate ﬁndingstissue subcutaneously whereas men are more likely to deposit fat
viscerally35. This is particularly relevant to our ﬁndings because,
although circulating levels of both leptin and insulin are proportional
to fat mass36, the levels of each reﬂect different fat depots. Leptin
levels correlate better with subcutaneous adipose tissue37e40, which
isproportionally larger inwomenwhereas insulin isbetter correlated
with visceral adipose tissue41, which is proportionally larger in men.
Our ﬁndings of stronger relationships between osteophytes-deﬁned
radiographic knee OA and leptin among women and between
osteophytes-deﬁned radiographic knee OA and an index of insulin
resistance among men may reﬂect the predominance of each as the
more important obesity-related hormone and fat depot for that sex.
This hypothesis is supported in studies using animal models where
thebrainsofmale ratsaremore sensitive to insulinbut female ratsare
more sensitive to leptin42. Furthermore, for a given amount of fat
mass, women have higher circulating leptin levels37e40 but increases
in body fat among women are associated with smaller decreases in
insulin sensitivity as compared to men43.
The sex dimorphismwith respect to leptin and insulin may also
be related to differences in sex steroid metabolism and levels
amongmen andwomen. Estrogen levels are higher inwomen, even
postmenopausal women, and estrogen has been shown to induce
leptin secretion in women44. Further, male rats exposed to exoge-
nous estrogen have increased sensitivity to leptin42. Excess
androgens in men45 and women46 are associated with increased
insulin resistance but androgens have a negative association with
leptin levels in men47,48.
There have been very few studies of OA and cardiometabolic
measures that have included bothmen andwomen24,49e52, and few
have analyzed their data stratifying by gender. In the AGES Rey-
kjavik Study, carotid plaque severity and coronary calciﬁcations
were associated with hand OA52 and marginally associated with
total knee or hip replacements in women53 but not men. Our
ﬁnding of a “protective” effect for leptin among men is interesting
and has not been reported in any other studies. We hypothesizetes-deﬁned radiographic knee OA modeled separately by gender and obesity status,
BMI LDL-cz SBPx
OR (95% CI) OR (95% CI) OR (95% CI)
1.33 (1.29, 1.36) 1.05 (1.03, 1.06) 0.97 (0.96, 0.99)
1.01 (0.96, 1.05) 1.06 (1.04, 1.08) 0.88 (0.86, 0.90)
1.15 (1.12, 1.18) 1.00 (0.99, 1.01) 1.10 (1.09, 1.11)
1.18 (1.17, 1.20) 0.94 (0.93, 0.95) 1.09 (1.05, 1.13)
triglycerides and smoking status (current, former, never).
that are statistically signiﬁcant.
Fig. 3. OR (95% CI) of osteophytes-deﬁned radiographic knee OA associated with leptin
by gender and obesity status, NHANES III. Estimates from each of the four obesity by
sex models were adjusted for age, ethnicity, marital status, educational attainment,
smoking status, HOMA-IR, BMI, logtriglycerides, LDL-c, and SBP.
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ﬂuid leptin levels within the joint among women54,55.
Our ﬁnding of no association of BMI and osteophytes-deﬁned
radiographic knee OA among obese men is interesting, especially
given its importance among women and non-obese men. Given our
ﬁndings of a stronger relationship of HOMA-IR and knee OA among
obese men as compared to non-obese men, we hypothesize that
obese men may have proportionally greater depots of visceral fat,
which is associated with insulin resistance41, as compared to non-
obese men. This hypothesis is supported by our sensitivity anal-
yses in which waist:hip ratio, a proxy for central adiposity, was
associated with greater odds of knee OA among obese men but not
among non-obese men (data not shown). However, we do not have
direct measures of visceral fat to test this hypothesis.
This analysis extends previous work by Sowers et al.21 with
regard to cardiometabolic obesity and knee OA. That study reported
that the odds of knee OA were greatest among women who were
both obese and had cardiometabolic dysfunction; however, the
cardiometabolic measures were not considered individually. We
now report that leptin levels and a proxy indicator of insulin
resistance, in particular, are strongly and signiﬁcantly related to
knee OA status.
This investigation has substantial strengths. Notably, our
analytical approach considered obesity and gender-stratiﬁed
models of the cardiometabolic measures relative to osteophytes-
deﬁned radiographic knee OA status. Because many of the car-
diometabolic measures vary with respect to obesity, this approach
allowed us to examine their relationship with OA, independent of
obesity. In doing so, it was observed that, regardless of obesity
status, and after adjustment for BMI, cardiometabolic risk factors
are associated with OA prevalence. The decision to utilize gender-
stratiﬁed models allowed us to reveal important patterns in the
relationship of osteophytes-deﬁned radiographic knee OA status
and cardiometabolic measures. The nationally-representative
sample utilized in this analysis is a strength in that it provides
sufﬁcient data to address variation in age, sex, and race/ethnic
status.
Limitations of this report are that non-weight bearing
radiographs were used to determine OA status in the NHANES III
population and so our measure is truly reﬂective of osteophytes-
deﬁned radiographic knee OA status. Usage of non-weight
bearing radiographs means that measures of joint space narrow-
ing, a proxy measure of cartilage loss, cannot be ascertained. The
impact of cardiometabolic dysfunction may have a different rela-
tionship with cartilage loss as compared to measures of bone
overgrowth which were described by the KL scoring system.
However, utilization of the non-weight bearing radiographs should
not affect the measures of osteophytes and bone sclerosis, reﬂected
in the KL scoring we report here. The cross-sectional design ofNHANES is a limitation of this study so causality between
cardiometabolic measures and OA cannot be determined. We used
HOMA-IR as a proxy for insulin resistance because more sophisti-
cated estimates such as glucose clamp measures were not available
in this large epidemiologic dataset. While some studies have sug-
gested that HOMA-IR may not be a good marker of insulin resis-
tance in older adults56, a larger study demonstrated high
correlation between HOMA-IR and insulin sensitivity among older
individuals with and without impaired glucose tolerance57.
Additionally, although the hypothesized relationship between
cardiometabolic measures and knee OA operates under a paradigm
of increased systemic inﬂammation, we did not include the
measure of C-reactive protein (CRP), an inﬂammatory biomarker,
due to the known technical limitations of the available CRP assay in
this population.
The observations warrant further investigation in other pop-
ulations with data available on men and women. The NHANES
dataset only includes information about OA in the knee joints.
However, because knee joints may be vulnerable to damage asso-
ciated with increased mechanical loading due to obesity, conﬁr-
mation of these ﬁndings in populations with information about OA
in non-weight bearing joints is of high interest. Reproducibility of
these ﬁndings in other populations and across joint sites would
have important implications for intervention and treatment and
possibly indicate that effective therapies for OA prevention may
differ by sex.
Conclusion
We have reported consistent, statistically signiﬁcant associa-
tions of cardiometabolic biomarkers and osteophytes-deﬁned
radiographic knee OA among a nationally-representative sample
of US adults and conclude that cardiometabolic dysfunction is
related to knee OA prevalence over-and-above the effect imparted
by obesity. Furthermore, we describe a striking sex dimorphism in
the pattern (direction and magnitude) of cardiometabolic risk
factors relative to osteophytes-deﬁned radiographic knee OA. A
proxy measure of insulin resistance is associated with OA preva-
lence among men, whereas among women, leptin levels appear to
be more important. Considering the substantial implications for
primary and secondary interventions, replication of these ﬁndings
should be pursued in other populations with OA and car-
diometabolic data, especially in those populations including both
men and women.
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